G. Rodrigues, Susana; Mendoza, Yuly P.; Bosch, Jaime (2020). Beta-blockers in cirrhosis: Evidence-based indications and limitations. JHEP reports, 2(1), p. 100063. Elsevier 10.1016/j.jhepr.2019.12.001
|
Text
main_2_.pdf - Published Version Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND). Download (1MB) | Preview |
Non-selective beta-blockers (NSBBs) are the mainstay of treatment for portal hypertension in the setting of liver cirrhosis. Randomised controlled trials demonstrated their efficacy in preventing initial variceal bleeding and subsequent rebleeding. Recent evidence indicates that NSBBs could prevent liver decompensation in patients with compensated cirrhosis. Despite solid data favouring NSBB use in cirrhosis, some studies have highlighted relevant safety issues in patients with end-stage liver disease, particularly with refractory ascites and infection. This review summarises the evidence supporting current recommendations and restrictions of NSBB use in patients with cirrhosis.
Item Type: |
Journal Article (Review Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine > Hepatology 04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Hepatologie 04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Hepatologie 04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) 04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine |
UniBE Contributor: |
Gomes Rodrigues, Susana, Mendoza Jaimes, Yuly Paulin, Bosch Genover, Jaime |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
2589-5559 |
Publisher: |
Elsevier |
Language: |
English |
Submitter: |
Thi Thao Anh Pham |
Date Deposited: |
11 Jan 2021 10:06 |
Last Modified: |
02 Mar 2023 23:34 |
Publisher DOI: |
10.1016/j.jhepr.2019.12.001 |
PubMed ID: |
32039404 |
Uncontrolled Keywords: |
ACLF ACLF, acute-on-chronic liver failure AKI, acute kidney injury ALD, alcohol-related liver disease ARD, absolute risk difference AV, atrioventricular EBL, endoscopic band ligation GOV, gastroesophageal varices HRS, hepatorenal syndrome HVPG, hepatic venous pressure gradient IGV, isolated gastric varices IRR, incidence rate ratio ISMN, isosorbide mononitrate MAP, mean arterial pressure NASH, non-alcoholic steatohepatitis NNH, number needed to harm NNT, number needed to treat NR, not reported NSBBs NSBBs, non-selective beta-blockers OR, odds ratio PH, portal hypertension PHG, portal hypertensive gastropathy RCT, randomised controlled trials RR, risk ratio SBP, spontaneous bacterial peritonitis SCL, sclerotherapy TIPS, transjugular intrahepatic portosystemic shunt ascites cirrhosis portal hypertension spontaneous bacterial peritonitis varices |
BORIS DOI: |
10.48350/149908 |
URI: |
https://boris.unibe.ch/id/eprint/149908 |
Actions (login required)
 |
Edit item |